THCz: Small molecules with antimicrobial activity that block cell wall lipid intermediates

Area of Science:

• Medicinal Chemistry
• Microbiology
• Drug Discovery

Background:

• Antibiotic resistance necessitates the discovery of novel antibacterial agents.
• Bacterial cell wall synthesis is a validated target for antimicrobial development.

Purpose of the Study:

• To identify novel classes of antibacterial compounds targeting bacterial cell wall synthesis.
• To characterize the mechanism of action and potential of tetrahydrocarbazole (THCz) derivatives.

Main Methods:

• Development of a bacterial whole-cell screen utilizing pneumococcal autolysin-mediated lysis.
• Synthesis and evaluation of 1-amino substituted tetrahydrocarbazole (THCz) derivatives.
• Mode of action studies investigating inhibition of cell envelope biosynthesis.

Main Results:

• A novel class of tetrahydrocarbazoles (THCz) demonstrated broad-spectrum bactericidal activity against Gram-positive and Gram-negative pathogens.
• THCz compounds inhibit cell envelope synthesis by targeting undecaprenyl pyrophosphate-containing lipid intermediates.
• THCz effectively inhibited peptidoglycan, teichoic acid, and polysaccharide capsule biosynthesis simultaneously.

Conclusions:

• Tetrahydrocarbazoles (THCz) represent a promising scaffold for developing new cell wall-targeting antimicrobials.
• The ease of synthesis and modification of THCz offers advantages over existing lipid II-binding antibiotics.
• THCz show potential for combating antibiotic resistance due to their novel mechanism and lack of rapid resistance development in vitro.